Daily Current Affairs / FDA Approves Injectable Lenacapavir as Long-Acting HIV Prevention Option:
Category : Science and Tech Published on: June 21 2025
The U.S. FDA has approved injectable lenacapavir as a semiannual HIV prevention method. This follows positive outcomes from PURPOSE 1 & 2 clinical trials in 2024. The WHO welcomed the move, highlighting it as a significant step in expanding HIV prevention options with a long-acting, convenient alternative for vulnerable populations.
India drops to 85th rank in the Henley Passport Index as China climbs to 64th; Indian passport now offers visa-free access to 57 countries.
Read More....Lxme launches ‘LxmePay’, India’s first women-only UPI app that rewards transactions with digital gold to boost savings.
Read More....India’s gold reserves cross $100 billion for the first time as global bullion prices rise, making up 14.7% of total forex reserves.
Read More....India-Japan Fund invests ₹500 crore in Eka Mobility to boost EV manufacturing and strengthen Indo-Japan climate cooperation.
Read More....IWAI hands over Haldia Multimodal Terminal to IRC Natural Resources under PPP model as part of the Jal Marg Vikas Project.
Read More....Jyothi Surekha Vennam becomes first Indian woman to win a medal at Archery World Cup Final, clinching bronze in Nanjing.
Read More....Veteran actor Govardhan Asrani, known for his comic roles in classics like Sholay and Chupke Chupke, passes away at 84.
Read More....Zoravar Singh Sandhu wins bronze in men’s trap at ISSF Shotgun World Championships 2025 in Athens, marking India’s third world-level medal.
Read More....CDSCO launches a digital monitoring system to track high-risk pharmaceutical solvents in real time, ensuring safer medicines for all.
Read More....